Elanco Animal Health Share Price (NYSE: ELAN)

$18.36

▲

-0.09

(-0.49%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Elanco Animal Health Stock chart to analyse performance

Elanco Animal Health stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$18.17
Today's High:$18.56
$18.36
1.03%
Downside
Day's Volatility :2.1%
Upside
1.08%
52 Weeks Low:$8.02
52 Weeks High:$18.87
$18.36
56.32%
Downside
52 Weeks Volatility :57.5%
Upside
2.7%

Elanco Animal Health Stock Returns

Period	Elanco Animal Health Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	36.81%	3.6%	0.0%
6 Months	62.33%	-7.7%	0.0%
1 Year	18.68%	-12.6%	0.0%
3 Years	21.35%	9.5%	-4.7%

Elanco Animal Health Inc Key Stats

Check Elanco Animal Health key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$18.45
Open	$18.46
Today's High	$18.56
Today's Low	$18.17
Market Capitalization	$9.1B
Today's Volume	$71.3M
52 Week High	$18.87
52 Week Low	$8.02
Revenue TTM	$4.5B
EBITDA	$842.0M
Earnings Per Share (EPS)	$0.88
PE Ratio	20.85
Profit Margin	9.68%
Quarterly Earnings Growth YOY	1.17%
Return On Equity TTM	6.83%

Stock Returns calculator for Elanco Animal Health Stock including INR - Dollar returns

The Elanco Animal Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Elanco Animal Health investment value today

Current value as on today

₹1,23,965

Returns

₹23,965

(+23.97%)

Returns from Elanco Animal Health Stock

₹18,681 (+18.68%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Elanco Animal Health Stock

43%

Period: Jul 30, 2025 to Aug 29, 2025. Change in 30 Days versus previous period

Search interest for Elanco Animal Health Stock from India on INDmoney has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Elanco Animal Health Inc

Name
Holdings %
Name
Holdings %
Dodge & Cox
16.69%
FMR Inc
10.84%
PRIMECAP Management Company
10.42%
Vanguard Group Inc
9.63%
BlackRock Inc
4.78%
Dimensional Fund Advisors, Inc.
4.58%

Analyst Recommendation on Elanco Animal Health Stock

Rating

Trend

Buy

66%Buy

28%Hold

4%Sell

Based on 21 Wall street analysts offering stock ratings for Elanco Animal Health(by analysts ranked 0 to 5 stars)

Elanco Animal Health Share Price Target

What analysts predicted

Downside of 0.97%

Target:

$18.18

Current:

$18.36

Elanco Animal Health share price target is $18.18, a slight Downside of 0.97% compared to current price of $18.36 as per analysts' prediction.

Elanco Animal Health Stock Insights

Price Movement
In the last 1 month, ELAN stock has moved up by 30.0%
Increasing Revenue
Revenue is up for the last 3 quarters, 1.02B → 1.24B (in $), with an average increase of 9.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 67.0M → 11.0M (in $), with an average decrease of 83.6% per quarter
ELAN vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 35.1% return, outperforming this stock by 12.9%

Elanco Animal Health Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$3.1B	↑ 0.14%
Net Income	$67.9M	↓ 21.5%
Net Profit Margin	2.21%	↓ 0.61%

	FY20	Y/Y Change
Revenue	$3.3B	↑ 6.59%
Net Income	$-560.1M	↓ 924.89%
Net Profit Margin	-17.11%	↓ 19.32%

	FY21	Y/Y Change
Revenue	$4.8B	↑ 45.57%
Net Income	$-472.0M	↓ 15.73%
Net Profit Margin	-9.91%	↑ 7.2%

	FY22	Y/Y Change
Revenue	$4.4B	↓ 7.28%
Net Income	$-74.0M	↓ 84.32%
Net Profit Margin	-1.67%	↑ 8.24%

	FY23	Y/Y Change
Revenue	$4.4B	↓ 0.02%
Net Income	$-1.2B	↑ 1563.51%
Net Profit Margin	-27.87%	↓ 26.2%

	FY24	Y/Y Change
Revenue	$4.4B	↑ 0.5%
Net Income	$338.0M	↓ 127.46%
Net Profit Margin	7.61%	↑ 35.48%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$1.2B	↑ 16.43%
Net Income	$32.0M	↓ 122.7%
Net Profit Margin	2.66%	↑ 16.28%

	Q2 FY24	Q/Q Change
Revenue	$1.2B	↓ 1.74%
Net Income	$-50.0M	↓ 256.25%
Net Profit Margin	-4.22%	↓ 6.88%

	Q3 FY24	Q/Q Change
Revenue	$1.0B	↓ 13.01%
Net Income	$364.0M	↓ 828.0%
Net Profit Margin	35.34%	↑ 39.56%

	Q4 FY24	Q/Q Change
Revenue	$1.0B	↓ 0.97%
Net Income	$-8.0M	↓ 102.2%
Net Profit Margin	-0.78%	↓ 36.12%

	Q1 FY25	Q/Q Change
Revenue	$1.2B	↑ 16.96%
Net Income	$67.0M	↓ 937.5%
Net Profit Margin	5.62%	↑ 6.4%

	Q2 FY25	Q/Q Change
Revenue	$1.2B	↑ 4.02%
Net Income	$11.0M	↓ 83.58%
Net Profit Margin	0.89%	↓ 4.73%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.6B	↑ 7.21%

	FY20	Y/Y Change
Profit	$1.6B	↑ 0.37%

	FY21	Y/Y Change
Profit	$2.6B	↑ 63.75%

	FY22	Y/Y Change
Profit	$2.5B	↓ 4.79%

	FY23	Y/Y Change
Profit	$1.9B	↓ 22.63%

	FY24	Y/Y Change
Profit	$1.9B	↓ 1.5%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$690.0M	↑ 32.95%

	Q2 FY24	Q/Q Change
Profit	$558.0M	↓ 19.13%

	Q3 FY24	Q/Q Change
Profit	$405.0M	↓ 27.42%

	Q4 FY24	Q/Q Change
Profit	$389.0M	↓ 3.95%

	Q1 FY25	Q/Q Change
Profit	$684.0M	↑ 75.84%

	Q2 FY25	Q/Q Change
Profit	$577.0M	↓ 15.64%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$224.1M	↓ 54.01%
Investing Cash Flow	$-234.8M	↑ 84.88%
Financing Cash Flow	$-304.8M	↑ 765.91%

	FY20	Y/Y Change
Operating Cash Flow	$-41.0M	↓ 118.3%
Investing Cash Flow	$-4.8B	↑ 1935.43%
Financing Cash Flow	$5.0B	↓ 1725.3%

	FY21	Y/Y Change
Operating Cash Flow	$483.0M	↓ 1278.05%
Investing Cash Flow	$-530.0M	↓ 88.91%
Financing Cash Flow	$210.0M	↓ 95.76%

	FY22	Y/Y Change
Operating Cash Flow	$452.0M	↓ 6.42%
Investing Cash Flow	$-179.0M	↓ 66.23%
Financing Cash Flow	$-549.0M	↓ 361.43%

	FY23	Y/Y Change
Operating Cash Flow	$271.0M	↓ 40.04%
Investing Cash Flow	$-169.0M	↓ 5.59%
Financing Cash Flow	$-83.0M	↓ 84.88%

	FY24	Y/Y Change
Operating Cash Flow	$541.0M	↑ 99.63%
Investing Cash Flow	$1.2B	↓ 785.21%
Financing Cash Flow	$-1.5B	↑ 1697.59%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$2.0M	↓ 98.73%
Investing Cash Flow	$37.0M	↓ 205.71%
Financing Cash Flow	$-27.0M	↓ 80.58%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$200.0M	↑ 9900.0%
Investing Cash Flow	$-33.0M	↓ 189.19%
Financing Cash Flow	$-93.0M	↑ 244.44%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$162.0M	↓ 19.0%
Investing Cash Flow	$1.2B	↓ 3869.7%
Financing Cash Flow	$-1.3B	↑ 1340.86%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$177.0M	↑ 9.26%
Investing Cash Flow	$-90.0M	↓ 107.23%
Financing Cash Flow	$-32.0M	↓ 97.61%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-4.0M	↓ 102.26%
Investing Cash Flow	$-58.0M	↓ 35.56%
Financing Cash Flow	$52.0M	↓ 262.5%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$237.0M	↓ 6025.0%
Investing Cash Flow	$-56.0M	↓ 3.45%
Financing Cash Flow	$-156.0M	↓ 400.0%

Elanco Animal Health Technicals Summary

Sell

Neutral

Buy

Elanco Animal Health is currently in a neutral trading position according to technical analysis indicators.

Elanco Animal Health Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Elanco Animal Health Inc	34.21%	62.33%	18.68%	21.35%	-36.82%
Haleon Plc Spon Ads	3.98%	-7.33%	-3.68%	63.96%	32.32%
United Therapeutics Corporation	10.96%	-1.69%	-16.16%	34.5%	71.41%
Zoetis Inc.	7.28%	-8.28%	-14.76%	-0.08%	-2.3%
Neurocrine Biosciences Inc.	8.87%	21.94%	9.87%	33.42%	19.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Elanco Animal Health Inc	20.85	20.85	9.38	0.88	0.07	0.01	NA	13.64
Haleon Plc Spon Ads	21.53	21.53	3.14	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	11.9	11.9	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.97	26.97	2.53	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	41.3	41.3	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Elanco Animal Health Inc	Buy	$9.1B	-36.82%	20.85	9.68%
Haleon Plc Spon Ads	Buy	$43.4B	32.32%	21.53	13.81%
United Therapeutics Corporation	Buy	$13.8B	71.41%	11.9	40.36%
Zoetis Inc.	Buy	$69.3B	-2.3%	26.97	27.83%
Neurocrine Biosciences Inc.	Buy	$13.8B	19.91%	41.3	13.88%

About Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Organization	Elanco Animal Health
Employees	9000
CEO	Mr. Jeffrey N. Simmons
Industry	Process Industries

Key Management of Elanco Animal Health Inc

Name	Title
Mr. Jeffrey N. Simmons	President, CEO & Director
Dr. Ramiro Martin Cabral	Executive VP & President of Elanco International
Mr. Todd S. Young J.D.	Advisor
Dr. Ellen de Brabander Ph.D.	Executive Vice President of Research, Development & Regulatory Affairs
Mr. Timothy J. Bettington	Executive Vice President of Corporate Strategy & Market Development
Mr. Robert M. VanHimbergen	Executive VP & CFO
Mr. James M. Meer	Senior VP & Chief Accounting Officer
Mr. Chris Keeley	Senior VP & Chief Information Officer
Mr. David S. Kinard	Executive Vice President of Human Resources, Corporate Communications & Administration
Ms. Shiv O'Neill	Executive Vice President, General Counsel & Corporate Secretary

Important FAQs about investing in ELAN Stock from India :

What is Elanco Animal Health share price today?

Elanco Animal Health share price today is $18.36 as on August 30, 2025 at 1:29 am IST at the close of the market. Elanco Animal Health share today touched a day high of $18.56 and a low of $18.17.

What is the 52 week high and 52 week low for Elanco Animal Health share?

Elanco Animal Health share touched a 52 week high of $18.87 and a 52 week low of $8.02. Elanco Animal Health stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $18.36, lower by 2.7% versus the 52 week high.

How to invest in Elanco Animal Health Stock (ELAN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Elanco Animal Health on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Elanco Animal Health Shares that will get you 0.0817 shares as per Elanco Animal Health share price of $18.36 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Elanco Animal Health Stock (ELAN) from India?

Indian investors can start investing in Elanco Animal Health (ELAN) shares with as little as ₹88.286 or $1 (as of August 30, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Elanco Animal Health stock (as per the Rupee-Dollar exchange rate as on August 30, 2025). Based on Elanco Animal Health share’s latest price of $18.36 as on August 30, 2025 at 1:29 am IST, you will get 0.5447 shares of Elanco Animal Health. Learn more about fractional shares .

What are the returns that Elanco Animal Health has given to Indian investors in the last 5 years?

Elanco Animal Health stock has given -36.82% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?